Centrais Elétricas Brasileiras S.A. - Eletrobrás ( NYSE: EBR) Q4 2024 Earnings Conference Call March 14, 2025 10:00 AM ET ...

Mapletree is executing well on capital recycling, and risks relating to asset write-offs will be less of a concern going ...

Halozyme Therapeutics sees strong Q4 2024 growth, driven by ENHANZE platform royalties. Click here to find out why HALO stock is a Hold.